1Kannel, WB, Kannel, C, Paffenbarger, RS, et al. (1987) Heart rate and cardiovascular mortality: the Framingham Study. Am Heart J 113, 1489–1494.
2Balanescu, S, Corlan, AD, Dorobantu, M, et al. (2004) Prognostic value of heart rate variability after acute myocardial infarction. Med Sci Monit 10, CR307–CR315.
3Dekker, JM, Schouten, EG, Klootwijk, P, et al. (1997) Heart rate variability from short electrocardiographic recordings predicts mortality from all causes in middle-aged and elderly men. The Zutphen Study. Am J Epidemiol 145, 899–908.
4Cernes, R, Zimlichman, R & Shargorodsky, M (2008) Arterial elasticity in cardiovascular disease: focus on hypertension, metabolic syndrome and diabetes. Adv Cardiol 45, 65–81.
5Neutel, JM, Smith, DH, Graettinger, WF, et al. (1992) Dependency of arterial compliance on circulating neuroendocrine and metabolic factors in normal subjects. Am J Cardiol 69, 1340–1344.
6Greiser, KH, Kluttig, A, Schumann, B, et al. (2009) Cardiovascular diseases, risk factors and short-term heart rate variability in an elderly general population: the CARLA study 2002–2006. Eur J Epidemiol 24, 123–142.
7Jeppesen, J, Hein, HO, Suadicani, P, et al. (1998) Triglyceride concentration and ischemic heart disease: an eight-year follow-up in the Copenhagen Male Study. Circulation 97, 1029–1036.
8Assmann, G, Schulte, H & von Eckardstein, A (1996) Hypertriglyceridemia and elevated lipoprotein(a) are risk factors for major coronary events in middle-aged men. Am J Cardiol 77, 1179–1184.
9Laederach-Hofmann, K, Mussgay, L & Ruddel, H (2000) Autonomic cardiovascular regulation in obesity. J Endocrinol 164, 59–66.
10Matsumoto, T, Miyawaki, T, Ue, H, et al. (1999) Autonomic responsiveness to acute cold exposure in obese and non-obese young women. Int J Obes Relat Metab Disord 23, 793–800.
11Spraul, M, Ravussin, E, Fontvieille, AM, et al. (1993) Reduced sympathetic nervous activity. A potential mechanism predisposing to body weight gain. J Clin Invest 92, 1730–1735.
12Troisi, RJ, Weiss, ST, Parker, DR, et al. (1991) Relation of obesity and diet to sympathetic nervous system activity. Hypertension 17, 669–677.
13Acree, LS, Montgomery, PS & Gardner, AW (2007) The influence of obesity on arterial compliance in adult men and women. Vasc Med 12, 183–188.
14Glasser, SP (2000) On arterial physiology, pathophysiology of vascular compliance, and cardiovascular disease. Heart Dis 2, 375–379.
15Mehta, JL, Lopez, LM, Lawson, D, et al. (1988) Dietary supplementation with omega-3 polyunsaturated fatty acids in patients with stable coronary heart disease. Effects on indices of platelet and neutrophil function and exercise performance. Am J Med 84, 45–52.
16Mozaffarian, D, Geelen, A, Brouwer, IA, et al. (2005) Effect of fish oil on heart rate in humans: a meta-analysis of randomized controlled trials. Circulation 112, 1945–1952.
17Christensen, JH, Christensen, MS, Dyerberg, J, et al. (1999) Heart rate variability and fatty acid content of blood cell membranes: a dose–response study with n-3 fatty acids. Am J Clin Nutr 70, 331–337.
18Villa, B, Calabresi, L, Chiesa, G, et al. (2002) Omega-3 fatty acid ethyl esters increase heart rate variability in patients with coronary disease. Pharmacol Res 45, 475.
19Ninio, DM, Hill, AM, Howe, PR, et al. (2008) Docosahexaenoic acid-rich fish oil improves heart rate variability and heart rate responses to exercise in overweight adults. Br J Nutr 100, 1–7.
20Calder, PC (2004) n-3 Fatty acids and cardiovascular disease: evidence explained and mechanisms explored. Clin Sci (Lond) 107, 1–11.
21Milte, CM, Coates, AM, Buckley, JD, et al. (2008) Dose-dependent effects of docosahexaenoic acid-rich fish oil on erythrocyte docosahexaenoic acid and blood lipid levels. Br J Nutr 99, 1083–1088.
22Prisant, LM, Pasi, M, Jupin, D, et al. (2002) Assessment of repeatability and correlates of arterial compliance. Blood Press Monit 7, 231–235.
23Malik, M (1996) Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation 93, 1043–1065.
24Herrington, DM, Kesler, K, Reiber, JC, et al. (2003) Arterial compliance adds to conventional risk factors for prediction of angiographic coronary artery disease. Am Heart J 146, 662–667.
25Fox, K, Ford, I, Steg, PG, et al. (2008) Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial. Lancet 372, 807–816.
26Nestel, P, Shige, H, Pomeroy, S, et al. (2002) The n-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid increase systemic arterial compliance in humans. Am J Clin Nutr 76, 326–330.
27McVeigh, GE, Brennan, GM, Cohn, JN, et al. (1994) Fish oil improves arterial compliance in non-insulin-dependent diabetes mellitus. Arterioscler Thromb 14, 1425–1429.
28Yokoyama, M, Origasa, H, Matsuzaki, M, et al. (2007) Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet 369, 1090–1098.
29Metcalf, RG, James, MJ, Gibson, RA, et al. (2007) Effects of fish-oil supplementation on myocardial fatty acids in humans. Am J Clin Nutr 85, 1222–1228.
30Ninio, DM, Murphy, KJ, Howe, PR, et al. (2005) Dietary fish oil protects against stretch-induced vulnerability to atrial fibrillation in a rabbit model. J Cardiovasc Electrophysiol 16, 1189–1194.
31Kang, JX & Leaf, A (1994) Effects of long-chain polyunsaturated fatty acids on the contraction of neonatal rat cardiac myocytes. Proc Natl Acad Sci U S A 91, 9886–9890.
32Gudbjarnason, S & Hallgrimsson, J (1976) Prostaglandins and polyunsaturated fatty acids in heart muscle. Acta Biol Med Ger 35, 1069–1080.